1186921001: POSSIBLY REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\POSSIBLY REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2021. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

4668053013 POSSIBLY REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

4668054019 POSSIBLY REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
POSSIBLY REPLACED BY association reference set (foundation metadata concept)	est un(e) (attribut)	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust]	rhinite allergique causée par le pollen
Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust]	Allergy to animal protein
Allergy: [allergic rhinitis due to other allergens] or [named animals or animal products] or [hay fever] or [house dust]	Allergy to house dust (finding)
Animal protein and epidermal substance (substance)	matière animale
Animal protein and epidermal substance (substance)	Animal protein
Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) (finding)	American Joint Committee on Cancer cM1 (qualifier value)
Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) (finding)	American Joint Committee on Cancer allowable value
Blind hypotensive eye	Phthisis bulbi
Blind hypotensive eye	Atrophy of globe of eye
Blind hypotensive eye (disorder)	Atrophy of globe of eye
Blind hypotensive eye (disorder)	Phthisis bulbi
Drainage of intracranial space, subarachnoid or subdural by incision or trephination	Drainage of cerebral subdural space by incision or trephination
drainage de l'espace intracrânien, subarachnoïdien ou subdural par incision ou trépanation	Drainage of cerebral subarachnoid space by incision or trephination
drainage de l'espace intracrânien, subarachnoïdien ou subdural par incision ou trépanation	Drainage of cerebral subdural space by incision or trephination
Drainage of intracranial space, subarachnoid or subdural by incision or trephination	Drainage of cerebral subarachnoid space by incision or trephination
drainage de l'espace intracrânien, subarachnoïdien ou subdural par incision ou trépanation	drainage de l'espace épidural encéphalique par incision et trépanation
Drainage of intracranial space, subarachnoid or subdural by incision or trephination	drainage de l'espace épidural encéphalique par incision et trépanation
artères nasales postérieure, latérale et septale entières	Entire lateral nasal artery (body structure)
artères nasales postérieure, latérale et septale entières	artère nasale dorsale entière
Lansoprazole 15mg m/r capsule/naproxen 250mg tablet (product)	Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug)
Lansoprazole 15mg m/r capsule/naproxen 250mg tablet (product)	Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)
Lansoprazole 15mg m/r capsule/naproxen 375mg tablet (product)	Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)
Lansoprazole 15mg m/r capsule/naproxen 375mg tablet (product)	Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug)
Lansoprazole 15mg m/r capsule/naproxen 500mg tablet (product)	Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug)
Lansoprazole 15mg m/r capsule/naproxen 500mg tablet (product)	Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug)
Naproxen 500mg tablet and misoprostol 200micrograms tablet pack (product)	Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug)
Naproxen 500mg tablet and misoprostol 200micrograms tablet pack (product)	Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug)
Naproxen 500mg tablet and misoprostol 200micrograms tablet pack (product)	Product containing precisely misoprostol 200 microgram/1 each conventional release vaginal tablet (clinical drug)
Overriding left ventriculoarterial valve (disorder)	Overriding aorta
Overriding left ventriculoarterial valve (disorder)	Aortic valve overriding ventricular septum (disorder)
Structure of posterior, lateral and septal nasal arteries	Structure of dorsal nasal artery
Structure of posterior, lateral and septal nasal arteries	Lateral nasal artery
T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis (finding)	cN1
T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis (finding)	American Joint Committee on Cancer cT3 (qualifier value)
T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis (finding)	cN1
T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis (finding)	American Joint Committee on Cancer cT3 (qualifier value)
T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria (finding)	cT3b
T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria (finding)	American Joint Committee on Cancer cT3a (qualifier value)
T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria (finding)	American Joint Committee on Cancer cT3c (qualifier value)
T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria (finding)	American Joint Committee on Cancer cT3d (qualifier value)
Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor (finding)	cTis
Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor (finding)	cTis(Paget)
Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget's disease of the nipple with no tumor (finding)	cTis(DCIS)
pT3a,b category (finding)	American Joint Committee on Cancer pT3b (qualifier value)
pT3a,b category (finding)	American Joint Committee on Cancer pT3a (qualifier value)
pT3a,b: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades 5 mm or less beyond the border of the muscularis propria (colon/rectum) (finding)	American Joint Committee on Cancer pT3b (qualifier value)
pT3a,b: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades 5 mm or less beyond the border of the muscularis propria (colon/rectum) (finding)	American Joint Committee on Cancer pT3a (qualifier value)
pT3c,d category (finding)	American Joint Committee on Cancer pT3d (qualifier value)
pT3c,d category (finding)	pT3c
pT3c,d: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades greater than 5 mm beyond the border of the muscularis propria (colon/rectum) (finding)	pT3c
pT3c,d: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades greater than 5 mm beyond the border of the muscularis propria (colon/rectum) (finding)	American Joint Committee on Cancer pT3d (qualifier value)
Animal protein and epidermal allergen (substance)	matière animale
Animal protein and epidermal allergen (substance)	Animal protein
y - During therapy/following treatment	American Joint Committee on Cancer yp stage group allowable value (qualifier value)
y - During therapy/following treatment	American Joint Committee on Cancer ypN category allowable value (qualifier value)
y - During therapy/following treatment	American Joint Committee on Cancer ypT category allowable value (qualifier value)

Reference Sets

Canada English language reference set (foundation metadata concept)

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4668053013	POSSIBLY REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
4668054019	POSSIBLY REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)